United States · FDA National Drug Code directory

ENT Support

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43742-2061_ff28cb48-6713-4c91-b05c-bbc92b795c1d
Product NDC
43742-2061
Form
LIQUID
Composition / generic term
Pulsatilla (Pratensis), Euphorbium Officinarum, Luffa Operculata, Mercurius Iodatus Ruber, Argentum Nitricum, Hepar Sulphuris Calcareum, Influenzinum (2022-2023), Sinusitisinum, Aspergillus Niger, Candida Albicans, Gallicum Acidum, Mucor Racemosus, Mutabile Bacillus (Bach)
Labeler
Deseret Biologicals, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20221201 / 20280908

Source-listed ingredients

  • PULSATILLA PRATENSIS WHOLE — 4 [hp_X]/mL
  • EUPHORBIA RESINIFERA RESIN — 6 [hp_X]/mL
  • LUFFA OPERCULATA FRUIT — 6 [hp_X]/mL
  • MERCURIC IODIDE — 8 [hp_X]/mL
  • SILVER NITRATE — 10 [hp_X]/mL
  • CALCIUM SULFIDE — 10 [hp_X]/mL
  • INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
  • INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) — 12 [hp_X]/mL
  • SINUSITISINUM — 17 [hp_X]/mL
  • ASPERGILLUS NIGER VAR. NIGER — 10 [hp_C]/mL
  • CANDIDA ALBICANS — 10 [hp_C]/mL
  • GALLIC ACID MONOHYDRATE — 10 [hp_C]/mL
  • MUCOR RACEMOSUS — 10 [hp_C]/mL
  • ESCHERICHIA COLI — 30 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (43742-2061-1) · 43742-2061-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →